Patient Presentation

Patient’s Changing ConditionMultiple Considerations To Balance

VALIANTHigh Early Risk of SCA

Implications of β-Blocker Underuse

Prior To Device Implantation

DINAMIT Trial – 40-Day Wait

HAT - Home Use of Automated ExternalDefibrillators for Sudden Cardiac Arrest

Wearable Cardioverter Defibrillator

Adherence to WCD Use

WCDBridging the Waiting Period

Cleveland Clinic Post-PCI Registry WCD Use in Post-PCI Low EF Patients Associated With

Improved Survival

Case

Patients With Low EF Following CABG

SCA Risk During Recovery

Patients With Low EF Following CABG

WCD Associated with Reduced Total Mortality

Case

MERIT-HFMechanism of Death in Heart Failure

Medical Therapy Optimization Required Prior to Managing Long-

Term Arrhythmic Risk

Other Indications Where WCD Might Be of Use?

Care Team Model

Heart Rhythm SocietySudden Cardiac Death Primary Prevention Protocols

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)